Holland & Knight Attorneys Nancy Bostic, Morgan Ivey, Lindsay Sheehy and Marisa Terrenzi Recognized Among The Deal's "Top Women in Dealmaking 2023"
MIAMI (April 3, 2023) – Holland & Knight attorneys Nancy Bostic, Morgan Ivey, Lindsay Sheehy and Marisa Terrenzi were recognized among The Deal's "Top Women in Dealmaking 2023."
The Deal's Top Women in Dealmaking list honors attorneys who have displayed excellence in their respective legal fields, including mergers and acquisitions, private equity, restructuring and activist investing.
Ms. Bostic is a partner in Holland & Knight's Houston office. She focuses her practice on representation of public and private companies and private equity funds in securities issuances, acquisitions and dispositions of assets and equity, joint ventures, recapitalizations, financings and change-of-control transactions valued in the billions.
Ms. Ivey, an associate in the firm's Nashville office, assists healthcare clients with a wide range of strategic transactions, including recapitalizations, leveraged buy-outs, mergers, acquisitions, joint ventures and divestitures involving physician practices, behavioral healthcare facilities, dental practices and other healthcare platforms. She also represents clients in the sale of portfolio companies and investments involving private equity and other strategic buyers.
Ms. Sheehy is a partner in the firm's Stamford, Connecticut, office and counsels public and private companies in mergers, acquisitions, dispositions, cross-border transactions, joint ventures, private equity and venture capital financings, restructurings, corporate governance and general corporate matters.
Ms. Terrenzi is a partner based in Holland & Knight's Tysons, Virginia, office and practices principally in the areas of business and corporate law, with an emphasis on mergers and acquisitions and general corporate matters. Her clients are engaged in a variety of industry sectors, including software services, government contracts and information technology. She has represented a number of leading venture capital and private equity firms in numerous transactions as well as a wide range of early stage and later stage companies.